Aggregation of Cat Platelets in Vitro

Th. B Tschopp

doi:10.1055/s-0038-1654191

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1970; 17(03): 601-620
DOI: 10.1055/s-0038-1654191

Originalarbeiten – Original Articles – Travaux Originaux

Schattauer GmbH

Aggregation of Cat Platelets in Vitro

Authors

Th. B Tschopp

¹Department of Experimental Medicine, Fa. Hoffmann-La Roche and Co. Ldt., Basle, Switzerland

Abstract

Summary

Aggregation of cat platelets in the citrated plasma is examined by means of Born’s absorptiometer. A marked tendency of the platelets of this species to spontaneous aggregation necessitated first of all the development of an improved technique of blood collection.

A hypothesis according to which 5-HT is released from the platelets, explains the absence of oscillations on the base line of the absorptiometer, the absence of platelet swelling, when ADP is added, and the effect of stirring on the aggregation curves in cat PRP. The average volume of cat platelets amounts to 10.46 μ³ when directly fixed in the blood, when fixed from PRP to 12.17 μ³, when fixed from stirred PRP to 13.51 μ³.

In low concentrations (0.3-2 μM) ADP produce reversible aggregation; in narrowly restricted, individually dissimilar mean concentrations irreversible aggregation in two phases and in high concentrations, irreversible aggregation in one phase. Like ADP serotonin produces 2 phase irreversible aggregation in concentrations of 3-10 μM, but unlike ADP, the aggregation velocity decreases again with high 5-HT concentrations (>100 μM). Adrenaline does not produce aggregation and it is likely that adenosine and adenosine monophosphate inhibit the aggregation by serotonin but not by ADP. Species differences in the aggregation of human, rabbit and cat platelets are discussed.

Full Text

References

References
1 Baumgartner H. B. 5-hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets. J. Physiol 201: 409-423 1969;
2 Baumgartner H. B, Born G. V. B. Effects of 5-hydroxytryptamine on platelet aggregation. Nature 218: 137-141 1968;
3 Baumgartner H. B, Born G. V. B. 5-hydroxytryptamine in rabbit platelets and their aggregation. J. Physiol 194: 92P-93P 1968;
4 Baumgartner H. B, Born G. V. B. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets. J. Physiol 201: 397-408 1968;
5 Baumgartner H. B, Thoenen H, Tranzer J. P. Accumulation of 5-hydroxydopamine in 5-HT storage organelles of cat platelets and concomitant changes in platelet aggregation. Experientia (Basel) 25: 857-860 1969;
6 Behnke O. Electron microscopic observations on the membrane systems of the rat blood platelet. Anat. Bee 158: 121-137 1967;
7 Bizzozero J. Über einen neuen Formbestandteil des Blutes und dessen Rolle bei der Thrombose und Blutgerinnung. Virchows Arch. Path. Anat 90: 261-332 1882;
8 Born G. V. B. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929 1962;
9 Born G. V. B. The effects of substances related to adenosine on blood vessels and on blood platelets. Kreislaufmessungen, 4. Freiburger Colloquium über Kreislaufmessungen, 4.-6.4. 1963 in Freiburg i. Br. 1-13 (1963).
10 Born G. V. R. The influence of adrenaline on platelet aggregation. Proc. Soc. exp. Biol. (N.Y.) 3: 71-72 1968;
11 Born G. V. B, Gross M. J. Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature 197: 974-976 1963;
12 Born G. V. B, Hornykiewicz O, Stafford A. The uptake of adrenaline and noradrenaline by blood platelets of the pig. Brit. J. Pharmacol 13: 411-414 1958;
13 Born G. V. B, Hume M. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature 215: 1027-1029 1967;
14 Born G. V. B, D. CL B Mills G. C, Roberts K. Potentiation of platelet aggregation by adrenaline. J. Physiol 191: 43P-44P 1967;
15 Bull B. S, Zucker M. B. Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents. Proc. Soc. exp. Biol. (N.Y.) 120: 296-301 1965;
16 Caen J, Michel H, Hermansky F, Allain J. P, Besson P. Le comportement des plaquettes sanguines de proc. C. R. Acad. Sci. (Paris) 161: 2455-2458 1967;
17 Constantine J. W. Aggregation of guinea-pig platelets by adenosine diphosphate. Nature 210: 162-169 1966;
18 Gonstantine J. W. Aggregation and adhesion of rat platelets. Nature 214: 1084-1086 1967;
19 Gross M. J. Effect of fibrinogen on the aggregation of platelets by adenosine diphosphate. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 524-527 1964;
20 Evans G, Packham M. A, Nishizawa E. E, Mustard J. F, Murphy E. A. The effect of acetylsalicylic acid on platelet function. J. exp. Med 128: 877-894 1968;
21 Gasic G. J, Gasic T. B, Stewart C. C. Antimetastatic effects associated with platelet reduction. Proc. nat. Acad. Sci 61: 46-52 1968;
22 Grant J. L, Britton M. G, Kurtz T. E. Measurement of red blood cell volume with the electronic cell counter. Amer. J. clin. Path 33: 138-143 1960;
23 Gross R, Niemeyer G, Reuter H. Untersuchungen über die Aggregation menschlicher Blutplättchen. I. Standardisierte Methoden zur quantitativen Bestimmung der Aggregation. Klin. Wschr. Nr 18: 931-939 1967;
24 Haslam J. R. Mechanism of blood platelet aggregation. In: Physiology of Hemostasis and Thrombosis. Ed. Johnson S. A, and Seegers W. H. Thomas; Springfield, Ill.: 88-112 1967
25 Hawkey C. M, Symons G. Variation in ADP-induced platelet aggregation in vitro in primates as a result of differences in plasma ADP inhibitor levels. Thrombos. Diathes. haemorrh. (Stuttg.) 19: 29-35 1968;
26 Herrmann R. G, Griggs V. G. Effect of counting solution and antihistaminics on platelet volume. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 705-712 1967;
27 Holzbauer M, Vogt M. The concentration of adrenaline in the peripheral blood during insulin hypoglycaemia. Brit. J. Pharmacol 2: 249-252 1954;
28 Hughes F. B, Brodie B. B. The mechanism of serotonin and catecholamine uptake by platelets. J. Pharmacol, exp. Ther 127: 96-102 1959;
29 Long R. F, Bessin A. W. Inhibition of 5-hydroxytryptamine uptake by platelets in vitro and in vivo. Biochem. J 82: 4p-5p 1962;
30 Lowenhaupt R, Nathan P. Platelet accumulation observed by electron microscopy in the early phase of renal allotransplant rejection. Nature 220: 822-825 1968;
31 MacMillan D. G, Oliver M. F. The initial changes in platelet morphology following the addition of adenosine diphosphate. J. Atheroscler. Res 5: 440-444 1965;
32 Mills D. G. B, Roberts G. C. K. Membrane active drugs and the aggregation of human blood platelets. Nature 213: 35-38 1967;
33 Mustard F, Packham M. A, Rowsell H. C, Jorgensen L. The role of thrombogenic factors in atherosclerosis. Ann. N. Y. Acad. Sci 149: 848-859 1968;
34 O’Brien J. R. A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. clin. Path 17: 275-281 1964;
35 Paasonen M. K. Platelet 5-hydroxytryptamine as a model in pharmacology. Ann. Med. exp. Fenn 46: 416-422 1968;
36 Paasonen M. K, Solatunturi E. Monoamine oxidase in mammalian blood platelets. Ann. Med. exp. Fenn 43: 98-100 1965;
37 Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Brit. J. Pharmacol 32: 1-16 1968;
38 Pletscher A, Tranzer J. P. Action of reserpine and Imipramine on intracellular storage of 5-hydroxytryptamine in blood platelets. Experientia (Basel) 23: 289-291 1967;
39 Sinakos Z, Gaen J. P. Platelet aggregation in mammalians (human, rat, rabbit, guinea-pig, horse, dog). A comparative study. Thrombos. Diathes. haemorrh. (Stuttg.) 17: 99-111 1967;
40 Snipes R. L, Thoenen H, Tranzer J. P. Fine structural localization of exogenous 5-HT in vesicles of adrenergic nerve terminals. Experientia (Basel) 24: 1026-1027 1968;
41 Solomon H. M, Ashley G, Spirt N, Abrams W. B. The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitro. Clin. Pharmacol. Ther 10: 229-238 1969;
42 Stehbens W. E, Biscoe T. J. The ultrastructure of early platelet aggregation in vivo. Amer. J. Path 50: 219-243 1967;
43 Street D. M, Roberts D. J. The presence of dopamine in cat spleen and blood. J. Pharm. Pharmacol 21: 199-201 1969;
44 Studer A. Experimental platelet thrombus. In: Pathogenesis and Treatment of Thromboembolic Diseases. G. K. Schattauer; Stuttgart: 109-130 1966
45 Thoenen H, Hürlimann A, Haefely W. The effect of postganglionic sympathetic stimulation on the isolated perfused spleen of the cat. Helv. physiol. pharmacol. Acta 21: 17-26 1963;
46 Tocantins L. M. Mammalian blood platelet in health and disease. Medicine 17: 155 1938;
47 Tranzer J. P, Baumgartner H. R. Filling gaps in the vascular endothelium with blood platelets. Nature 216: 1126-1128 1967;
48 Vendsalu A. Studies on adrenaline and noradrenaline in human plasma. Acta physiol. scand. 49 173 1960
49 Wilcoxon P. Probability tables for individual comparisons by ranking methods. Biometrics 3: 119-123 1947;